These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 22943680)

  • 21. Framing cardiovascular disease event risk prediction.
    Stone JA
    Can J Cardiol; 2011; 27(2):171-3. PubMed ID: 21459265
    [No Abstract]   [Full Text] [Related]  

  • 22. Lipid Profile Consultation.
    Bachorik PS
    MD Comput; 1987; 4(4):50-2. PubMed ID: 3613938
    [No Abstract]   [Full Text] [Related]  

  • 23. Lipid modification: cardiovascular risk assessment and the modification of blood lipids for the primary and secondary prevention of cardiovascular disease.
    Robson J
    Heart; 2008 Oct; 94(10):1331-2. PubMed ID: 18701534
    [No Abstract]   [Full Text] [Related]  

  • 24. [The cardiovascular effects of fish oil].
    Engel S; Singer P
    Z Arztl Fortbild (Jena); 1992 Jun; 86(11):547-50. PubMed ID: 1621398
    [No Abstract]   [Full Text] [Related]  

  • 25. Cardiovascular risk factors and recommended lipid goals attainment among patients referred in a tertiary care lipid clinic.
    Pirro M; Del Giorno R; Lupattelli G; Mannarino MR; Roscini AR; Covelli D; Schillaci G; Pasqualini L; Bagaglia F; Siepi D; Mannarino E
    Eur J Intern Med; 2011 Aug; 22(4):412-7. PubMed ID: 21767761
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence of dyslipidaemia in patients treated with lipid-modifying drugs in the Netherlands. Part of the dyslipidaemia international survey.
    Strang AC; Kaasjager HA; Basart DC; Stroes ES
    Neth J Med; 2010 Apr; 68(4):168-74. PubMed ID: 20421658
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The science of lipidology impacts underwriting and improves mortality.
    Gleeson R
    J Insur Med; 2009; 41(3):197-200. PubMed ID: 20377099
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative prognostic utility of conventional and novel lipid parameters for cardiovascular disease risk prediction: do novel lipid parameters offer an advantage?
    Manickam P; Rathod A; Panaich S; Hari P; Veeranna V; Badheka A; Jacob S; Afonso L
    J Clin Lipidol; 2011; 5(2):82-90. PubMed ID: 21392721
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Standardization of the methods of lipid determination according to WHO in the regional project of prevention of cardiovascular diseases in Friuli-Venezia Giulia].
    Grafnetter D; Feruglio GA; Vanuzzo D
    G Ital Cardiol; 1996 Mar; 26(3):287-97. PubMed ID: 8690184
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sesame supplementation does not improve cardiovascular disease risk markers in overweight men and women.
    Wu JH; Hodgson JM; Puddey IB; Belski R; Burke V; Croft KD
    Nutr Metab Cardiovasc Dis; 2009 Dec; 19(11):774-80. PubMed ID: 19346113
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effects of resistance training on cardiovascular disease risk factors in postmenopausal women: a randomized-controlled trial.
    Gelecek N; Ilçin N; Subaşi SS; Acar S; Demir N; Ormen M
    Health Care Women Int; 2012; 33(12):1072-85. PubMed ID: 23153344
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Randomized, controlled study of the effects of raloxifene on high sensitivity C-reactive protein and serum lipids.
    Oztas E; Kurtay G
    Arch Gynecol Obstet; 2011 Jan; 283(1):71-7. PubMed ID: 20012308
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lipid screening and cardiovascular health in childhood.
    Daniels SR; Greer FR;
    Pediatrics; 2008 Jul; 122(1):198-208. PubMed ID: 18596007
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Omega-3 fatty acids improve haemodynamic and haemorheologic parameters and lipid profiles in patients with cardiovascular diseases.
    Habon T; Kesmarky G; Toth K
    Eur Heart J; 2002 Jan; 23(1):89. PubMed ID: 11741369
    [No Abstract]   [Full Text] [Related]  

  • 35. [Antioxidant level and lipid metabolism in patients with cardiovascular disease].
    Beketova NA; Derbeneva SA; Spirichev VB; Pereverzeva OG; Kosheleva OV; Mal'tsev GIu; Vasil'ev AV; Pogozheva AV
    Vopr Pitan; 2007; 76(3):11-8. PubMed ID: 17674514
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Waist circumference and cardiovascular risk factors in prepubertal children.
    Maffeis C; Pietrobelli A; Grezzani A; Provera S; Tatò L
    Obes Res; 2001 Mar; 9(3):179-87. PubMed ID: 11323443
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Measuring lipids, blood pressure, and smoking.
    Hayman LL
    Cardiovasc Nurs; 1988; 24(6):49-50. PubMed ID: 3203361
    [No Abstract]   [Full Text] [Related]  

  • 38. [Moderate alcohol drinking protects against heart disease].
    Frid A
    Lakartidningen; 2000 Mar; 97(9):946-7. PubMed ID: 10741041
    [No Abstract]   [Full Text] [Related]  

  • 39. Comparison of two point-of-care lipid analyzers for use in global cardiovascular risk assessments.
    Dale RA; Jensen LH; Krantz MJ
    Ann Pharmacother; 2008 May; 42(5):633-9. PubMed ID: 18413684
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Study of basal lipid profile and alimentary lipaemia in cardiovascular disorders.
    Sharma RN; Kotiyal JP; Singh DS; Bisht DB
    J Assoc Physicians India; 1981 Aug; 29(8):597-602. PubMed ID: 7338492
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.